572 | PATIENT‐REPORTED OUTCOMES IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA PATIENTS TREATED WITH EPCORITAMAB: OVERALL AND SUBGROUP ANALYSIS BY BASELINE SYMPTOM BURDEN
Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
10.1002/hon.70096_572